290 related articles for article (PubMed ID: 22211881)
1. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
[TBL] [Abstract][Full Text] [Related]
3. Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications.
Cho YH; Craig ME; Januszewski AS; Benitez-Aguirre P; Hing S; Jenkins AJ; Donaghue KC
Diabet Med; 2017 Apr; 34(4):543-550. PubMed ID: 27770590
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.
Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB
Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products are associated with arterial stiffness in type 1 diabetes.
Llauradó G; Ceperuelo-Mallafré V; Vilardell C; Simó R; Gil P; Cano A; Vendrell J; González-Clemente JM
J Endocrinol; 2014 Jun; 221(3):405-13. PubMed ID: 24681829
[TBL] [Abstract][Full Text] [Related]
7. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.
Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Nakatani Y; Ohtoshi K; Hayaishi-Okano R; Kosugi K; Hori M; Yamasaki Y
Diabetes Care; 2005 Nov; 28(11):2716-21. PubMed ID: 16249545
[TBL] [Abstract][Full Text] [Related]
8. Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study.
van Eupen MG; Schram MT; van Sloten TT; Scheijen J; Sep SJ; van der Kallen CJ; Dagnelie PC; Koster A; Schaper N; Henry RM; Kroon AA; Smit AJ; Stehouwer CD; Schalkwijk CG
Hypertension; 2016 Oct; 68(4):956-63. PubMed ID: 27550921
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes mellitus.
Uruska A; Gandecka A; Araszkiewicz A; Zozulinska-Ziolkiewicz D
Diabet Med; 2019 May; 36(5):620-625. PubMed ID: 30706538
[TBL] [Abstract][Full Text] [Related]
10. Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence.
Hangai M; Takebe N; Honma H; Sasaki A; Chida A; Nakano R; Togashi H; Nakagawa R; Oda T; Matsui M; Yashiro S; Nagasawa K; Kajiwara T; Takahashi K; Takahashi Y; Satoh J; Ishigaki Y
J Atheroscler Thromb; 2016 Oct; 23(10):1178-1187. PubMed ID: 26961217
[TBL] [Abstract][Full Text] [Related]
11. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Skin Autofluorescence and Its Association with Glycated Hemoglobin, Cardiovascular Risk Markers, and Concomitant Chronic Diseases in Children with Type 1 Diabetes.
Jankowska M; Szadkowska A; Pietrzak I; Chrzanowski J; Sołek J; Fendler W; Mianowska B
Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931293
[TBL] [Abstract][Full Text] [Related]
13. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.
Jenkins AJ; Zhang SX; Rowley KG; Karschimkus CS; Nelson CL; Chung JS; O'Neal DN; Januszewski AS; Croft KD; Mori TA; Dragicevic G; Harper CA; Best JD; Lyons TJ; Ma JX
Diabet Med; 2007 Dec; 24(12):1345-51. PubMed ID: 17971181
[TBL] [Abstract][Full Text] [Related]
14. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?
Hofmann B; Adam AC; Jacobs K; Riemer M; Erbs C; Bushnaq H; Simm A; Silber RE; Santos AN
Exp Gerontol; 2013 Jan; 48(1):38-44. PubMed ID: 22588061
[TBL] [Abstract][Full Text] [Related]
16. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
[TBL] [Abstract][Full Text] [Related]
17. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
[TBL] [Abstract][Full Text] [Related]
18. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Cleary PA; Braffett BH; Orchard T; Lyons TJ; Maynard J; Cowie C; Gubitosi-Klug RA; Way J; Anderson K; Barnie A; Villavicencio S;
Diabetes Technol Ther; 2013 Jun; 15(6):466-74. PubMed ID: 23882708
[TBL] [Abstract][Full Text] [Related]
19. The relationship between advanced glycation end products and ocular circulation in type 2 diabetes.
Hashimoto K; Kunikata H; Yasuda M; Ito A; Aizawa N; Sawada S; Kondo K; Satake C; Takano Y; Nishiguchi KM; Katagiri H; Nakazawa T
J Diabetes Complications; 2016; 30(7):1371-7. PubMed ID: 27209548
[TBL] [Abstract][Full Text] [Related]
20. High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes.
Di Pino A; Currenti W; Urbano F; Scicali R; Piro S; Purrello F; Rabuazzo AM
Nutr Metab Cardiovasc Dis; 2017 Nov; 27(11):978-984. PubMed ID: 28958695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
